Elon Musk cleared of defamation in 'pedo guy' tweet trial
An attorney has told a Los Angeles jury it would be reasonable to award $190 million in damages to a British cave explorer who is suing Elon Musk for allegedly branding him as a pedophile during a Twitter spat.
Bipartisan Medicare drug bill gets makeover to lower copays
A bipartisan Senate bill to curb prescription drug costs for Medicare enrollees is getting a makeover that would lower copays and make it easier for seniors to budget.
US firms keep hiring, easing worries of weakening economy
US employers add robust 266,000 jobs in November, unemployment falls to 50-year low of 3.5%.
Amazon blaming Trump over Pentagon contract loss, judge says
Amazon is arguing in a court case that President Donald Trump's bias against the company harmed its chances at winning a $10 billion Pentagon contract.
Google co-founders step aside as antitrust scrutiny heats up
Google co-founders Larry Page and Sergey Brin step down as executives of parent company Alphabet, will remain on board.
DHS retreats on possible facial screening of US citizens
The Homeland Security Department says it has no plans to force U.
NATO researchers: Social media failing to stop manipulation
NATO-affiliated researchers say social media companies are failing to stop manipulated activity.
Uber reports more than 3,000 sexual assaults on 2018 rides
In a long anticipated safety report, ride-sharing giant Uber says more than 3,000 sexual assaults were reported during its U.
Huawei asks court to throw out US telecom funds ban
Huawei asking U.S. court to throw out rule that bars use of government money to buy its equipment on security grounds.
Pelosi sets Medicare showdown on drug costs and new benefits
House Speaker Nancy Pelosi is setting a showdown vote next week on her bill empowering Medicare to negotiate prices for costly prescription drugs.
Phone-in-cheek: Spike seen in cellphone-linked face injuries
Researchers say careless cellphone use can lead to facial cuts, bruises and fractures.
Senators urge Medicare to allow seniors a drug plan do-over
Leading senators are urging Medicare to allow seniors concerned about their drug plan pick for next year to switch if they believe they received inaccurate information.
US report: Prescription drug prices down slightly last year
A government report says prices for prescription drugs edged down 1% last year, driven by declines for generics and slow growth for brand-name medications.
Experts split sharply over experimental Alzheimer’s drug
A company that claims it has the first drug to slow mental decline from Alzheimer's disease made its case to scientists Thursday, disclosing more results to help explain why one study of it succeeded and another failed.
Supreme Court temporarily shields Trump bank records
President Donald Trump and three of his children are asking the Supreme Court to shield records held by Deutsche Bank and Capital One from House Democrats.
China waiving tariff hikes on US soybeans, pork
China's finance ministry says Beijing is waiving tariff hikes on U.
Stocks advance as investors eyes jobs report, trade talks
Global shares are up as investors await what's expected to be a healthy U.
FAA seeks to fine Boeing $3.9 million for faulty jet parts
Boeing faces a possible fine of nearly $4 million after safety regulators say the company installed faulty parts on the wings of some Boeing 737 jets.
Microsoft shareholders defeat 2 activist proposals
Microsoft's shareholders have voted to defeat two proposals by activist investors calling for the company to add a rank-and-file employee on its board of directors and report on gender disparities in company salaries.
Tufts University severs ties with family behind OxyContin
Tufts University is ending its relationship with the billionaire family that owns OxyContin Purdue Pharma.